Category Archives: Competition Law

Competition Law Copyright

Google Books Settlement Rejected


In a decision sure to have important implications for antitrust, copyright law, digital archiving and class action issues, a federal district court in New York rejected the settlement that Google had reached with layers of publishing houses and authors themselves, to digitise books to create a universal library of digital content. After a significant lull in the updates on the Google Book Settlement, the long-awaited decision has finally come through, putting to rest the $125 million deal, in its current…


Read More »
Competition Law Innovation

Guest Post: Innovation for the 21st Century


We are very honoured to bring you a guest post from Professor Michael Carrier, a renowned thought leader in IP and competition policy. His post titled “Fostering Innovation by Fixing US Law” captures the central arguments he makes in a very engaging book titled “Innovation for the 21st Century: Harnessing the Power of Intellectual Property and Antitrust Law“. Given that India is soon going to face very challenging jurisprudential issues around the application of competition law to intellectual property, Michael’s…


Read More »
Competition Law Innovation

Intellectual Property Rights and Competition Law: Friends or Foes?


In several previous posts, we have debated on aspects of the interaction of IP with competition law. These issues are all the more important in Indian intellectual property now, with the coming into force of several provisions of the Competition Act, 2002. The possibility of tensions between IP and competition law seems to have been present in the mind of the legislature, when it made some IP-specific exceptions in Section 3(5) of the Act. Among the important questions which are…


Read More »
Competition Law

Guest Post: Hanging on the Telephone: Apple’s App Store fiasco and what the FCC is doing about it


SpicyIP is pleased to bring to you a guest post by Chaitanya Ramchandran, a good friend of mine who has very recently graduated from the National Law School of India University, Bangalore. During his stint at law school Chaitanya was editor in chief of NLSIU’s flagship tech law journal – Indian Journal of Law & Technology whose archives can be accessed here. His post focuses on the competition law issues arising out of Apple’s latest policies regarding the applications that…


Read More »
Competition Law

The Competition Commission: Separation of Power troubles again?


Earlier on this blog, a series of posts had covered some of the IP-related issues in the Competition Act, 2002. Now, with several of the Acts provisions in force, I intend to look at some aspects of the Act in detail. Particularly, I intend to focus on the following areas; though with the help of our readers’ comments, I hope that the discussion shall cover other related areas too: 1. The Competition Commission 2. Exclusive agreements: When are they anti-competitive?…


Read More »
Competition Law Patent

Part I: European Commission’s Competition Inquiry into the Pharmaceutical Sector


The investigation into the anti-competitive conditions in the pharmaceutical sector was begun by the European Union Commission on January 15, 2008. The Preliminary Report was released in December 2008 (Refer to previous post titled “Prelim report points to anti-competitive practices in EU’s Pharma industry”). The investigation; “Pharmaceutical Sector Inquiry” launched by the Commission under Article 17 of Regulation 1/2003 (of 16 December 2002) on the implementation of the rules on Competition laid down in Articles 81 and 82 of the…


Read More »
Competition Law Patent

(KEI) Cracking Open Anti-competitive Practices in the Developing World: Complaints, Amendments and Waivers.


In Feb 2007 Knowledge Ecology International (KEI) had brought to the notice of the US Federal Trade Commission the practices of Gilead Sciences Inc. with respect to certain patented drugs used in the treatment of HIV and AIDS of Gilead that they believed was wholly anticompetitive. As Shamnad recently posted, this is with respect to a same drug that is facing pre-grant opposition in India from a Brazillian organisation. The study of these documents made for very interesting reading, one…


Read More »
Competition Law Patent

The Competition Act, Patents and Over Hyped Drugs – Part III


Lets start today with an overview of some of the sections of the Competition Act that might have a bearing on any patent related competition issues: Chapter II of the Act proscribes Anti Competitive agreements including tie-in arrangements, exclusive supply agreements, exclusive distribution agreements, refusals to deal and resale price maintenance. Sub-section (5) of section 3 however provides (inter alia) that the section shall not be read to restrict the “right of any person to restrain any infringement of, or…


Read More »
Competition Law Patent

The Competition Act, Patents and Over Hyped Drugs – Part II


Before taking off from where I stopped yesterday, I must thank V. Ramachandran of V.R. Associates for informing me that the Competition (Amendment) Act, 2007 has been passed and sections 1, 2, 6 to 9, 11, 12, 17 to 18, 27, 29 to 30, 32, 40 to 49 (except sections 53B to 53U) were notified on 12/10/07. Now to continue… A report I submitted to the NHRC in 1999 looked at prices of insulin (a life saving drug) in India…


Read More »
Competition Law Patent

The Competition Act, Patents and Over Hyped Drugs – Part I


Shamnad drew my attention to a recent news report in the Business Standard, “Law not Equipped to Handle Pharma Monopoly: Experts” The report states: “With anti-competitive practices of global pharma companies increasingly coming under regulatory scrutiny internationally, Indian public interest groups and the domestic medicine makers complain that India’s competitive laws are not equipped to face a similar situation of monopoly in the sales of patent protected medicines in the country.” The report provides two view points: (1) Leena Menghaney,…


Read More »